SCHEMBL8136100

SCHEMBL8136100

C[SiH](C)OC(CCc1ccc(C(C)(C)C)c(N)c1)C(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP24A1 Q07973 2/20 0.32
ANO1 Q5XXA6 1/20 0.31
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8069576 0.74 SLC6A2 (0.35) CYP24A1
SCHEMBL8115820 0.70
SCHEMBL3240507 0.70 ALDH1A1 (0.42) ANO1GAA
SCHEMBL8114181 0.68
SCHEMBL8136094 0.68 RIPK1 (0.30)
SCHEMBL5857370 0.67 BCHE (0.36) CYP24A1GAA
SCHEMBL1627502 0.66 PPARA (0.38) CYP24A1
SCHEMBL26422443 0.66 ESR1 (0.42) ANO1GAA
SCHEMBL3246604 0.66 ANO1 (0.40) ANO1GAA
SCHEMBL7478664 0.65 MEN1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763524-B1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO CO (JP) 2000-08-23 EP disclosed
US-6040339-A TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA OR ARTERIOSCLEROSIS IN A MAMMAL SANKYO COMPANY, LIMITED (JP) 2000-03-21 US disclosed
US-5880147-A Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use SANKYO COMPANY, LIMITED (JP) 1999-03-09 US disclosed
EP-0763524-A1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO COMPANY LIMITED (JP) 1997-03-19 EP disclosed